Select Medical (NYSE:SEM) Issues FY 2024 Earnings Guidance

Select Medical (NYSE:SEM - Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 1.960-2.200 for the period, compared to the consensus estimate of 2.030. The company issued revenue guidance of $6.9 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion.

Select Medical Trading Up 10.5 %

SEM stock traded up $3.00 during midday trading on Friday, hitting $31.45. 1,993,545 shares of the company's stock were exchanged, compared to its average volume of 578,204. Select Medical has a 1-year low of $21.28 and a 1-year high of $33.51. The business has a 50-day simple moving average of $28.36 and a two-hundred day simple moving average of $25.87. The stock has a market capitalization of $4.04 billion, a PE ratio of 16.46, a P/E/G ratio of 1.10 and a beta of 1.38. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.32.

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Friday, February 23rd. The health services provider reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.31 by $0.05. The company had revenue of $1.66 billion for the quarter, compared to analysts' expectations of $1.64 billion. Select Medical had a net margin of 3.65% and a return on equity of 16.93%. Select Medical's revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.22 earnings per share. On average, sell-side analysts predict that Select Medical will post 2.03 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 13th. Shareholders of record on Friday, March 1st were paid a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date was Thursday, February 29th. Select Medical's dividend payout ratio (DPR) is 26.18%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Benchmark reiterated a buy rating and issued a $39.00 price objective on shares of Select Medical in a report on Friday. StockNews.com raised shares of Select Medical from a hold rating to a buy rating in a research report on Friday, March 22nd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of Moderate Buy and a consensus target price of $34.40.

Insider Buying and Selling

In other news, Chairman Robert A. Ortenzio sold 50,000 shares of Select Medical stock in a transaction dated Monday, April 8th. The stock was sold at an average price of $29.90, for a total value of $1,495,000.00. Following the completion of the transaction, the chairman now owns 6,689,668 shares in the company, valued at approximately $200,021,073.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 19.14% of the stock is currently owned by insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.